Howland Capital Management LLC Gilead Sciences, Inc. Transaction History

Howland Capital Management LLC

$2.05 Billion
Q1 2024

A detailed history of Howland Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Howland Capital Management LLC holds 18,585 shares of GILD stock, worth $1.35 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

18,585

Previous 21,167 12.2%

Holding current value

$1.35 Million

Previous $1.71 Million 20.6%

% of portfolio

0.07%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$71.58 - $87.29 $184,819 - $225,382	-2,582 Reduced 12.2%	18,585 $1.36 Million
Q4 2023 Jan 23, 2024	SELL	$73.27 - $83.09 $11,356 - $12,878	-155 Reduced 0.73%	21,167 $1.71 Million
Q3 2023 Oct 17, 2023	SELL	$73.94 - $80.67 $369,995 - $403,672	-5,004 Reduced 19.01%	21,322 $1.6 Million
Q2 2023 Jul 28, 2023	SELL	$76.01 - $86.7 $34,204 - $39,015	-450 Reduced 1.68%	26,326 $2.03 Million
Q1 2023 May 05, 2023	SELL	$77.31 - $88.08 $12,756 - $14,533	-165 Reduced 0.61%	26,776 $2.22 Million

Q4 2022 Jan 30, 2023	SELL	$62.32 - $89.47 $62,818 - $90,185	-1,008 Reduced 3.61%	26,941 $2.31 Million
Q3 2022 Oct 17, 2022	SELL	$59.54 - $68.01 $426,246 - $486,883	-7,159 Reduced 20.39%	27,949 $1.72 Million
Q2 2022 Jul 22, 2022	BUY	$57.72 - $65.01 $56,911 - $64,099	986 Added 2.89%	35,108 $2.17 Million
Q1 2022 Apr 27, 2022	BUY	$57.92 - $72.58 $11,526 - $14,443	199 Added 0.59%	34,122 $2.03 Million
Q4 2021 Jan 26, 2022	SELL	$64.88 - $73.64 $39,771 - $45,141	-613 Reduced 1.77%	33,923 $2.46 Million
Q3 2021 Oct 25, 2021	SELL	$67.69 - $73.03 $112,974 - $121,887	-1,669 Reduced 4.61%	34,536 $2.41 Million
Q2 2021 Jul 28, 2021	SELL	$63.47 - $69.35 $142,299 - $155,482	-2,242 Reduced 5.83%	36,205 $2.49 Million
Q1 2021 Apr 28, 2021	SELL	$60.0 - $68.46 $1.98 Million - $2.26 Million	-32,941 Reduced 46.14%	38,447 $2.49 Million
Q4 2020 Jan 26, 2021	SELL	$56.65 - $64.55 $1.42 Million - $1.62 Million	-25,029 Reduced 25.96%	71,388 $4.16 Million
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $834,561 - $1.05 Million	-13,439 Reduced 12.23%	96,417 $6.09 Million
Q2 2020 Jul 15, 2020	SELL	$72.34 - $84.0 $622,051 - $722,316	-8,599 Reduced 7.26%	109,856 $8.45 Million
Q1 2020 Apr 27, 2020	BUY	$62.63 - $80.22 $37,578 - $48,132	600 Added 0.51%	118,455 $8.86 Million
Q1 2020 Apr 13, 2020	SELL	$62.63 - $80.22 $494,401 - $633,256	-7,894 Reduced 6.28%	117,855 $8.81 Million
Q4 2019 Jan 23, 2020	SELL	$61.62 - $67.78 $746,156 - $820,748	-12,109 Reduced 8.78%	125,749 $8.17 Million
Q3 2019 Oct 22, 2019	SELL	$62.51 - $69.0 $439,757 - $485,415	-7,035 Reduced 4.86%	137,858 $8.74 Million
Q2 2019 Jul 17, 2019	SELL	$61.87 - $69.38 $4.3 Million - $4.82 Million	-69,470 Reduced 32.41%	144,893 $9.79 Million
Q1 2019 Apr 22, 2019	SELL	$62.53 - $70.05 $249,182 - $279,149	-3,985 Reduced 1.83%	214,363 $13.9 Million
Q4 2018 Jan 23, 2019	SELL	$60.54 - $79.0 $992,734 - $1.3 Million	-16,398 Reduced 6.99%	218,348 $13.7 Million
Q3 2018 Oct 25, 2018	SELL	$71.28 - $78.92 $1.47 Million - $1.63 Million	-20,648 Reduced 8.08%	234,746 $18.1 Million
Q2 2018 Jul 23, 2018	SELL	$64.88 - $75.68 $105,819 - $123,434	-1,631 Reduced 0.63%	255,394 $18.1 Million
Q1 2018 May 02, 2018	BUY	$72.84 - $88.8 $638,442 - $778,332	8,765 Added 3.53%	257,025 $19.4 Million
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $586,347 - $688,288	-8,241 Reduced 3.21%	248,260 $17.8 Million
Q3 2017 Oct 30, 2017	BUY	$72.11 - $85.47 $18.5 Million - $21.9 Million	256,501	256,501 $20.8 Million

Others Institutions Holding GILD

# of Institutions

1,892

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $90.9B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.

Account

Howland Capital Management LLC Gilead Sciences, Inc. Transaction History